Ram Mudambi

Public Member

Member Since: September 26, 2015

X: @RMInnovation

Frank M. Speakman Professor of Strategy Fox School of Business Temple University

Interest:

Industry:

Interviewee:

Authored Resources

12971 views

Indian drug makers moved from reverse engineering generics to world-class R&D after policy and patent reforms changed the incentives for innovation.